Aronoff Associates
This article was originally published in The Gray Sheet
Executive Summary
In an article on device biomaterials ("The Gray Sheet" May 9, p. 25), the name of the New York City-based firm commissioned by the Health Industry Manufacturers Association to study the effects of DuPont's withdrawal of medical device biomaterials from the market was misspelled